Nautilus Biotechnology Inc

+0.09 (+3.17%)
Earnings Announcements

Nautilus Biotechnology Reports Quarterly Loss Per Share $0.12

Published: 08/02/2022 11:30 GMT
Nautilus Biotechnology Inc (NAUT) - Nautilus Biotechnology Reports Second Quarter 2022 Financial Results.
Qtrly Loss per Share $0.12.
Cash, Cash Equivalents, and Investments Were $334.9 Million As of June 30, 2022.
Q3 Earnings per Share View $-0.19 -- Refinitiv Ibes Data (analyst estimates).
Anticipate Our Cash Runway Extending Well Into 2025.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.